Cerebral palsy results from non-progressive brain injury around the time of birth, producing motor dysfunction, spasticity and variable cognitive or sensory impairment.
Cerebral palsy results from non-progressive brain injury around the time of birth, producing motor dysfunction, spasticity and variable cognitive or sensory impairment. Stem-cell research targets neuroprotection and plasticity: placental mesenchymal stem cells are studied for anti-inflammatory effects that may limit secondary neuronal loss and reduce spasticity, while neurogenic cells are explored to support damaged motor circuitry and synaptic reorganisation. Because the brain injury is fixed, intervention aims to limit secondary damage and enhance plasticity rather than reverse established damage. Trials enrol children and young adults; reported outcomes include spasticity reduction and motor-function changes, usually alongside intensive physiotherapy.
| Индикативна цена · България (ЕС) | €3,000–€8,000 |
|---|---|
| Глобален диапазон на пазарната цена | €6,000–€7,650 (bookimed.com) |
| Основни видове клетки, които се изучават | MSCs from Amniotic Membrane, Neurogenic Cells |
| Статус на одобрение | Експериментален |
| Регистрирани проучвания (ClinicalTrials.gov) | 41 · 2 recruiting now |
For the clinic's own description, see how Stem Plus describes its Cerebral Palsy programme ↗.
Forty-one registered trials and 2 recruiting studies investigate stem-cell approaches in cerebral palsy, mostly in Asia and Latin America. Small cohorts describe reduced muscle tone and improved gross-motor scores within 3–12 months; most lack adequate controls or blinding. Placebo effects in rehabilitation are substantial, and concurrent physiotherapy confounds attribution. No large randomised trial has shown stem cells superior to intensive physiotherapy or established interventions; few studies follow beyond 12 months.
Depending on assessment, a Cerebral Palsy protocol may draw on:
Indicative European costs are roughly €4,000–€7,500 per course. Paediatric infusions add safety monitoring and often use multiple small doses over weeks. Some protocols bundle intensive rehabilitation, adding further cost. For context, physiotherapy, botulinum toxin and orthopaedic surgery are established, often insurance-covered interventions — the stem-cell figure is indicative and unproven.
Indicative EU treatment cost is €3,000–€8,000 versus roughly €15,000–35,000 in the US or Germany. Build your real all-in total with the cost calculator, see the Cerebral Palsy cost-by-country breakdown, or compare the best countries for Cerebral Palsy →
Before booking, check safety & regulation, the recovery climate, дали бихте могли да бъдете кандидат, and which cell type fits Cerebral Palsy.
Пълен Церебрална парализа ЧЗВ → · Разбор на разходите Церебрална парализа →
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
Useful tools & guides: Съм ли кандидат? · Какъв тип клетки? · Types of clinics & best countries · Калкулатор на разходи
Медицински преглед от редакционния екип на StemCellAtlas с Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка